Abstract
About this talk
Introduction: Immunotherapy revolutionizes the treatment of many different types of cancers. But it is associated with a myriad of Immune-related adverse events (irAEs). Patient-reported outcomes (PROs) are recognized as valuable tools for continuously collecting patient-centred data and are frequently used in oncology trials. However, a few studies researching ePRO follow-up approach on patients treated with immunotherapy that may reflect a lack of support services for this population.
Methods: The team co-developed a digital platform (V-Care) using ePROs for a new follow-up pathway for cancer patients receiving immunotherapy. We used multiple methods to functionalize the first three phases of the CeHRes roadmap. These phases were not performed sequentially but were interwoven all over the developmental process.
Results: The development of the application was categorized into two phases “user interface” (UI) and “user experience” (UX) designs. In the first phase, the pages of the application were segmented into
general categories. Based on the received feedback from all stakeholders, the application was modified. In phase two, the mock-up pages were sent to the Figma website. Also, Android Package Kit (APK) of the application was installed and tested several times on the mobile phone to proactively detect and fix any errors. After solving some technical issues and adjusting the errors on the android version to provide a better experience for the users, the iOS version of this application was developed.
Conclusion: The findings from our project can be used to investigate whether symptoms collected by the ePRO tools on cancer patients being treated with ICIs follow symptoms reported in clinical trials and if there are linked to specific symptoms that do occur.
Speaker
About the speaker
